We had previously detected a transforming oncogene, designated PTC, in 25% of 20 papillary thyroid carcinomas. In order to characterize further the transforming activity of this tumour histotype, a new panel of tumour specimens from 16 patients was analysed by using a modified calcium phosphate-DNA coprecipitation transfection protocol. Tumour DNA from 10 patients (62%) displayed a transforming activity due to activation of three different oncogenes identified in four cases as PTC, in four cases as TRK, and in two cases as N-RAS. The same structural alterations of PTC and TRK (gene rearrangements) as well as of N-RAS (point mutation) detected in the NIH3T3 transformants, were also found in the original tumour DNAs, thus indicating that thei...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
We had previously detected a transforming oncogene, designated PTC, in 25% of 20 papillary thyroid c...
We recently detected a novel activated oncogene by transfection analysis on NIH 3T3 cells in five ou...
We recently detected a novel activated oncogene by transfection analysis on NIH 3T3 cells in five ou...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
Using DNA transfection analysis1 on NIH3T3 cells2, activated human oncogenes have been isolated from...
Malignant tumors of the thyroid gland vary considerably in aggressiveness, ranging from a well-diffe...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
We had previously detected a transforming oncogene, designated PTC, in 25% of 20 papillary thyroid c...
We recently detected a novel activated oncogene by transfection analysis on NIH 3T3 cells in five ou...
We recently detected a novel activated oncogene by transfection analysis on NIH 3T3 cells in five ou...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. Th...
Using DNA transfection analysis1 on NIH3T3 cells2, activated human oncogenes have been isolated from...
Malignant tumors of the thyroid gland vary considerably in aggressiveness, ranging from a well-diffe...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...